Dr. Franz-Werner Haas

Dr. Franz-Werner Haas is an accomplished executive in the biotechnology and pharmaceutical sectors, currently serving as the CEO of LimmaTech Biologics AG since July 2023. Prior to this role, Haas held the position of CEO and Chief Corporate Officer at CureVac from May 2012 to June 2023. Haas also served as Vice President Operations and General Counsel at SYGNIS Pharma AG from 2005 to 2012. Additional experience includes roles as General Counsel at Sirona Dental Systems and LION bioscience, as well as Director of Sales and Personal Assistant to the Management Board at SLH Group. Early in the career, Haas worked as a Referee of the Advocate General at the Court of Justice of the European Union. Academic credentials include a PhD and State Examinations in Law from Universität des Saarlandes, a Master of Laws in International Economic Law from The University of Edinburgh, and an EU Scholarship from KU Leuven.